| 0 |
GRANULICATELLA BACTERAEMIA |
1 |
0.0556 |
| 1 |
MONKEYPOX |
5 |
0.0181 |
| 2 |
ADENOVIRUS INTERSTITIAL NEPHRITIS |
1 |
0.0179 |
| 3 |
INTESTINE TRANSPLANT REJECTION |
1 |
0.0104 |
| 4 |
HEPATITIS INFECTIOUS MONONUCLEOSIS |
1 |
0.0103 |
| 5 |
SCEDOSPORIUM INFECTION |
6 |
0.0085 |
| 6 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
6 |
0.0083 |
| 7 |
ROSEOLOVIRUS TEST POSITIVE |
1 |
0.0082 |
| 8 |
ADENOVIRUS REACTIVATION |
1 |
0.0069 |
| 9 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
2 |
0.0067 |
| 10 |
ADENOVIRUS INFECTION |
15 |
0.0052 |
| 11 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
11 |
0.0052 |
| 12 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
7 |
0.0050 |
| 13 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0048 |
| 14 |
GRAFT VERSUS HOST DISEASE IN EYE |
1 |
0.0043 |
| 15 |
EPIPHYSIOLYSIS |
1 |
0.0040 |
| 16 |
INFECTIVE TENOSYNOVITIS |
1 |
0.0040 |
| 17 |
CANDIDA SEPSIS |
3 |
0.0033 |
| 18 |
ENTEROBACTER BACTERAEMIA |
1 |
0.0033 |
| 19 |
RENAL HYPERTENSION |
1 |
0.0032 |
| 20 |
GLOMERULOSCLEROSIS |
2 |
0.0032 |
| 21 |
NOROVIRUS TEST POSITIVE |
1 |
0.0031 |
| 22 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
8 |
0.0029 |
| 23 |
GRAFT VERSUS HOST DISEASE IN LIVER |
2 |
0.0028 |
| 24 |
AMYOTROPHY |
1 |
0.0026 |
| 25 |
TENOSYNOVITIS |
7 |
0.0025 |
| 26 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
11 |
0.0022 |
| 27 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
0.0021 |
| 28 |
RENAL TUBULAR DYSFUNCTION |
1 |
0.0018 |
| 29 |
CYTOMEGALOVIRUS COLITIS |
4 |
0.0017 |
| 30 |
KIDNEY FIBROSIS |
3 |
0.0017 |
| 31 |
DRY GANGRENE |
1 |
0.0016 |
| 32 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 33 |
T-LYMPHOCYTE COUNT DECREASED |
1 |
0.0015 |
| 34 |
DYSHIDROTIC ECZEMA |
1 |
0.0014 |
| 35 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
3 |
0.0013 |
| 36 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 37 |
BK VIRUS INFECTION |
4 |
0.0012 |
| 38 |
ENTEROVIRUS INFECTION |
1 |
0.0012 |
| 39 |
RENAL TUBULAR ATROPHY |
1 |
0.0011 |
| 40 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 41 |
CD4 LYMPHOCYTES DECREASED |
2 |
0.0009 |
| 42 |
BACTERIAL SEPSIS |
3 |
0.0009 |
| 43 |
ACIDOSIS |
7 |
0.0009 |
| 44 |
GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0009 |
| 45 |
EPSTEIN-BARR VIRAEMIA |
1 |
0.0009 |
| 46 |
INFECTION REACTIVATION |
1 |
0.0009 |
| 47 |
PELVIC ABSCESS |
1 |
0.0009 |
| 48 |
GASTROENTERITIS NOROVIRUS |
1 |
0.0008 |
| 49 |
GLYCOSURIA |
1 |
0.0007 |
| 50 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 51 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 52 |
VIRAEMIA |
1 |
0.0007 |
| 53 |
PATHOGEN RESISTANCE |
6 |
0.0007 |
| 54 |
PORTAL HYPERTENSION |
2 |
0.0006 |
| 55 |
NEPHROPATHY TOXIC |
7 |
0.0006 |
| 56 |
QUADRIPARESIS |
1 |
0.0006 |
| 57 |
EXTREMITY NECROSIS |
1 |
0.0006 |
| 58 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 59 |
FANCONI SYNDROME ACQUIRED |
1 |
0.0006 |
| 60 |
TRANSPLANT DYSFUNCTION |
1 |
0.0006 |
| 61 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 62 |
CYTOMEGALOVIRUS INFECTION |
9 |
0.0005 |
| 63 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 64 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 65 |
THROMBOTIC MICROANGIOPATHY |
5 |
0.0005 |
| 66 |
AZOTAEMIA |
2 |
0.0005 |
| 67 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 68 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 69 |
HYPERBILIRUBINAEMIA |
5 |
0.0005 |
| 70 |
VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0005 |
| 71 |
DRUG RESISTANCE |
12 |
0.0005 |
| 72 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
1 |
0.0005 |
| 73 |
CYTOMEGALOVIRUS VIRAEMIA |
2 |
0.0004 |
| 74 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1 |
0.0004 |
| 75 |
ACUTE GRAFT VERSUS HOST DISEASE |
2 |
0.0004 |
| 76 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 77 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
11 |
0.0004 |
| 78 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 79 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 80 |
RENAL TUBULAR DISORDER |
1 |
0.0004 |
| 81 |
ENCEPHALOPATHY |
8 |
0.0003 |
| 82 |
HERPES SIMPLEX |
2 |
0.0003 |
| 83 |
GRAFT VERSUS HOST DISEASE |
2 |
0.0003 |
| 84 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1 |
0.0003 |
| 85 |
FLUID OVERLOAD |
4 |
0.0003 |
| 86 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 87 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
0.0003 |
| 88 |
BLOOD BILIRUBIN INCREASED |
7 |
0.0003 |
| 89 |
HAEMOLYSIS |
2 |
0.0003 |
| 90 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 91 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 92 |
TRANSPLANT REJECTION |
2 |
0.0002 |
| 93 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 94 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 95 |
HEPATIC FAILURE |
7 |
0.0002 |
| 96 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 97 |
KIDNEY TRANSPLANT REJECTION |
1 |
0.0002 |
| 98 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 99 |
RASH VESICULAR |
1 |
0.0002 |
| 100 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 101 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 102 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 103 |
MALNUTRITION |
2 |
0.0002 |
| 104 |
ACUTE KIDNEY INJURY |
27 |
0.0002 |
| 105 |
ENTEROCOLITIS |
1 |
0.0002 |
| 106 |
BACTERAEMIA |
2 |
0.0002 |
| 107 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 108 |
CYTOPENIA |
2 |
0.0002 |
| 109 |
PANCYTOPENIA |
9 |
0.0002 |
| 110 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 111 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 112 |
SKIN LESION |
4 |
0.0001 |
| 113 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 114 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 115 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 116 |
HEPATOTOXICITY |
3 |
0.0001 |
| 117 |
RESPIRATORY FAILURE |
9 |
0.0001 |
| 118 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 119 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 120 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
1 |
0.0001 |
| 121 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 122 |
SEPTIC SHOCK |
5 |
0.0001 |
| 123 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 124 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 125 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 126 |
LEUKAEMIA |
1 |
0.0001 |
| 127 |
CHOLESTASIS |
2 |
0.0001 |
| 128 |
ATELECTASIS |
1 |
0.0001 |
| 129 |
ASCITES |
3 |
0.0001 |
| 130 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 131 |
SKIN INFECTION |
1 |
0.0001 |
| 132 |
SCAB |
1 |
0.0001 |
| 133 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 134 |
CARDIAC ARREST |
7 |
0.0001 |
| 135 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 136 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 137 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 138 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 139 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 140 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 141 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 142 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 143 |
PNEUMOTHORAX |
1 |
0.0001 |
| 144 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 145 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 146 |
CANDIDA INFECTION |
1 |
0.0001 |
| 147 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 148 |
DELIRIUM |
2 |
0.0001 |
| 149 |
HYPOTENSION |
11 |
0.0001 |
| 150 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 151 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 152 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 153 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 154 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 155 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 156 |
OFF LABEL USE |
40 |
0.0000 |
| 157 |
HYPOKALAEMIA |
2 |
0.0000 |
| 158 |
LEUKOPENIA |
2 |
0.0000 |
| 159 |
HAEMATEMESIS |
1 |
0.0000 |
| 160 |
HEPATITIS |
1 |
0.0000 |
| 161 |
SKIN ULCER |
1 |
0.0000 |
| 162 |
PNEUMONITIS |
1 |
0.0000 |
| 163 |
THROMBOCYTOPENIA |
4 |
0.0000 |
| 164 |
TACHYCARDIA |
3 |
0.0000 |
| 165 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 166 |
CYSTITIS |
1 |
0.0000 |
| 167 |
IMPAIRED HEALING |
1 |
0.0000 |
| 168 |
RENAL FAILURE |
4 |
0.0000 |
| 169 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 170 |
HYPERKALAEMIA |
1 |
0.0000 |
| 171 |
HYPOXIA |
1 |
0.0000 |
| 172 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 173 |
DYSURIA |
1 |
0.0000 |
| 174 |
COLITIS |
1 |
0.0000 |
| 175 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 176 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 177 |
SEIZURE |
3 |
0.0000 |
| 178 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 179 |
OVERDOSE |
5 |
0.0000 |
| 180 |
NEUTROPENIA |
3 |
0.0000 |
| 181 |
ILLNESS |
2 |
0.0000 |
| 182 |
PANCREATITIS |
1 |
0.0000 |
| 183 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 184 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 185 |
SEPSIS |
2 |
0.0000 |
| 186 |
HERPES ZOSTER |
1 |
0.0000 |
| 187 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 188 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 189 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 190 |
CARDIAC FAILURE |
1 |
0.0000 |
| 191 |
DIARRHOEA |
8 |
0.0000 |
| 192 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 193 |
DRUG INEFFECTIVE |
14 |
0.0000 |
| 194 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 195 |
HYPERTENSION |
2 |
0.0000 |
| 196 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 197 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 198 |
CHILLS |
1 |
0.0000 |
| 199 |
INFECTION |
1 |
0.0000 |
| 200 |
DRUG INTERACTION |
1 |
0.0000 |
| 201 |
TREMOR |
1 |
0.0000 |
| 202 |
PYREXIA |
2 |
0.0000 |
| 203 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 204 |
NAUSEA |
3 |
0.0000 |
| 205 |
WEIGHT DECREASED |
1 |
0.0000 |
| 206 |
DEATH |
3 |
0.0000 |
| 207 |
PNEUMONIA |
1 |
0.0000 |
| 208 |
ASTHENIA |
1 |
0.0000 |
| 209 |
PRURITUS |
1 |
0.0000 |
| 210 |
RASH |
1 |
0.0000 |
| 211 |
VOMITING |
1 |
0.0000 |